Last reviewed · How we verify

Daricon (OXYPHENCYCLIMINE)

FDA-approved approved Small molecule Quality 20/100

Daricon (Oxyphencyclimine) is a small molecule drug that targets the muscarinic acetylcholine receptor M1. It is classified as an oxyphencyclimine and is used to treat peptic ulcers. As an off-patent medication, Daricon is no longer protected by active patents, making it available as a generic option. However, there are currently no generic manufacturers listed. This medication's commercial status and availability may vary depending on the region and market.

At a glance

Generic nameOXYPHENCYCLIMINE
Drug classoxyphencyclimine
TargetMuscarinic acetylcholine receptor M1
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved
First approval1982

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions